Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Bolin Liu, PhD

Department of Genetics Stanley S. Scott Cancer Center School of Medicine Louisiana State University Health Sciences Center

Presented in Memory of Cecilia “CeCe” Curry, METAvivor Board Member

IGF-2 in Herceptin refractory HER2-positive breast cancer

Hui-Wen Lo, PhD

McGovern Medical School The University of Texas Health Science Center at Houston

Presented by Midland Park’s Third Annual Color Fun Run in memory of Ashley Rizzuto & Angela Rogers

Targeting Established Brain Metastases of Triple-negative Breast Cancer Using A Novel Combination of Two FDA-Approved BBB-permeable Kinase Inhibitors

Hui-Wen LO, PhD

McGovern Medical School at The University of Texas Health Science Center, Houston

Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Targeting Breast Cancer Brain Metastases by an FDA-Approved Antifungal Drug and its Novel Analog

Paul Lockman, PhD

West Virginia University

Timing of radiotherapy and chemotherapy to improve drug effect in brain metastases of breast cancer

Michael Lukey, PhD

Cornell University

Presented by Minneapolis Metsquerade in honor of Erin Remme

Targeting the unique metabolic profile of brain metastases in breast cancer

David Lum, PhD

Oklahoma Medical Research Foundation

Validation of patient-derived breast tumor grafts as predictors of tumor evolution and drug resistance

SOPHIA LUNT, PhD

Michigan State University

Targeting Sialic Acid Metabolism to Stop Metastatic Breast Cancer

Traci Lyons, PhD

University of Colorado Anschutz Medical Campus

Presented by Northwest Arkansas Metsquerade In Memory of Erin Leland

Targeting therapeutic vulnerabilities of endocrine therapy resistant ER+ metastatic breast cancer

TRACI LYONS, PHD

University of Colorado Anschutz Medical Campus

Characterizing the TME and SEMA7A expression in TNBC metastasis to improve targeted therapy

Ashley Makela, PhD

The Institute for Quantitative Health Science and Engineering, Michigan State University

Presented In Memory of Connie Cadwell by Miles4Metavivor

Understanding extracellular vesicle trafficking in established breast cancer metastases: In vivo tri-modal imaging provides long

Srinivas Malladi, PhD

UT Southwestern Medical Center

Presented in Honor of Abbey Rapoport

Targeting vulnerabilities of immune-evasive HER2+ Breast Adenocarcinoma Metastasis Initiating Cells

SENDURAI A. MANI, PhD

University of Texas MD Anderson Cancer Center

Targeting Cancer Stem Cells to Treat Metastasis